Matches in Wikidata for { <http://www.wikidata.org/entity/Q61601976> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q61601976 description "article scientifique publié en 2006" @default.
- Q61601976 description "article" @default.
- Q61601976 description "im Juli 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q61601976 description "wetenschappelijk artikel" @default.
- Q61601976 description "наукова стаття, опублікована в липні 2006" @default.
- Q61601976 name "Oxaliplatin and capecitabine (Xelox) in association with highly active antiretroviral therapy in advanced hepatocarcinoma HIV/HCV-infected patients" @default.
- Q61601976 name "Oxaliplatin and capecitabine" @default.
- Q61601976 type Item @default.
- Q61601976 label "Oxaliplatin and capecitabine (Xelox) in association with highly active antiretroviral therapy in advanced hepatocarcinoma HIV/HCV-infected patients" @default.
- Q61601976 label "Oxaliplatin and capecitabine" @default.
- Q61601976 prefLabel "Oxaliplatin and capecitabine (Xelox) in association with highly active antiretroviral therapy in advanced hepatocarcinoma HIV/HCV-infected patients" @default.
- Q61601976 prefLabel "Oxaliplatin and capecitabine" @default.
- Q61601976 P1433 Q61601976-3E613D7D-DD7F-4043-8EB4-3940E5CDC578 @default.
- Q61601976 P1476 Q61601976-87BAFC77-3548-4B17-8C2F-82D4AB7B82A5 @default.
- Q61601976 P2093 Q61601976-0544055D-B631-4FD4-AD51-0ACEF0337B6F @default.
- Q61601976 P2093 Q61601976-57E8CA74-41A7-42FC-BD0F-3A93A4A81847 @default.
- Q61601976 P2093 Q61601976-6FD38630-4CBC-4D92-98F7-0718314637FC @default.
- Q61601976 P304 Q61601976-44818136-FF93-44AF-978A-67FB86EBD541 @default.
- Q61601976 P31 Q61601976-A5E0DEF3-5D48-4543-B7B8-A01D655C8A09 @default.
- Q61601976 P356 Q61601976-EF825177-B741-4068-ADDC-5512886306ED @default.
- Q61601976 P433 Q61601976-8DEDE230-2C3E-41B4-AA0C-A3516C3C9856 @default.
- Q61601976 P478 Q61601976-A55334EF-571D-4413-BA4F-CB22446F166C @default.
- Q61601976 P50 Q61601976-3A8C52D3-9F4E-4F9E-A2D9-7B8BEB896996 @default.
- Q61601976 P50 Q61601976-52163CFA-D155-47C5-B446-7FADB3A5B069 @default.
- Q61601976 P50 Q61601976-9D1622DB-DAF5-4D49-8E44-DC31113D1161 @default.
- Q61601976 P577 Q61601976-21EB2F38-D51E-49A1-9427-DE6FB7CAE0B0 @default.
- Q61601976 P698 Q61601976-AD382F71-61B3-4BF3-B8B3-2B666CA9F013 @default.
- Q61601976 P921 Q61601976-1FD0C29E-2A8B-49F5-A871-F0572A6FBAD2 @default.
- Q61601976 P921 Q61601976-520934DC-4D82-4B42-B954-88DEDF588472 @default.
- Q61601976 P356 MDJ140 @default.
- Q61601976 P698 16798837 @default.
- Q61601976 P1433 Q326122 @default.
- Q61601976 P1476 "Oxaliplatin and capecitabine (Xelox) in association with highly active antiretroviral therapy in advanced hepatocarcinoma HIV/HCV-infected patients" @default.
- Q61601976 P2093 "A Lleshi" @default.
- Q61601976 P2093 "M Berretta" @default.
- Q61601976 P2093 "U Tirelli" @default.
- Q61601976 P304 "1176-1177" @default.
- Q61601976 P31 Q13442814 @default.
- Q61601976 P356 "10.1093/ANNONC/MDJ140" @default.
- Q61601976 P433 "7" @default.
- Q61601976 P478 "17" @default.
- Q61601976 P50 Q42991161 @default.
- Q61601976 P50 Q53394076 @default.
- Q61601976 P50 Q57079928 @default.
- Q61601976 P577 "2006-07-01T00:00:00Z" @default.
- Q61601976 P698 "16798837" @default.
- Q61601976 P921 Q420207 @default.
- Q61601976 P921 Q422327 @default.